论文部分内容阅读
药品不良反应(ADR)报告和监测,是指药品不良反应的发现、报告、评价和控制过程。由于药品的特殊性,上市前所能做的研究非常有限,需要通过广泛的临床应用才能发现其固有的风险。因此,通过加强药品不良反应报告和监测工作,及时发现药品潜在风险,并评价其风险效益比,不断完善药品的安全性信息,才能保护公众的用药安全。笔者结合自己在工作实践中遇到的问题,就基层药品不良反应监测问题进行分析
Adverse drug reactions (ADR) reporting and monitoring refer to the process of finding, reporting, evaluating, and controlling adverse drug reactions. Due to the particularity of medicines, the research that can be done before listing is very limited, and its inherent risk needs to be found through a wide range of clinical applications. Therefore, we can protect the public’s drug safety by strengthening the reporting and monitoring of adverse drug reactions, discovering the potential risks of drugs in a timely manner, evaluating the risk-benefit ratio and continuously improving the safety information of drugs. The author combines his own problems encountered in the work of practice, analysis of adverse drug reaction monitoring of primary drugs